• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[唾液酸神经节苷脂-1抗原固相免疫放射分析的初步基础与临床评估:1. 分析条件及正常值评估]

[Initial basic and clinical evaluation of a solid-phase immunoradiometric assay for sialyl SSEA-1 antigen: 1. Evaluation of assay conditions and normal values].

作者信息

Imura H, Endo J, Ohkura H, Ishii M, Ariyoshi Y, Abe O, Masamune O, Nishimoto Y, Fukushi Y, Orikasa S

出版信息

Gan To Kagaku Ryoho. 1987 May;14(5 Pt 1):1315-21.

PMID:2883936
Abstract

We describe a solid-phase immunoradiometric sandwich assay method for a new tumor marker, sialyl SSEA-1 (sialyl LeX-i), using RIA kits (prepared by Otsuka Assay Laboratories). The assay required only duplicate 20-microliter samples, and the concentration of sialyl SSEA-1 antigen in serum was determined with reference to a standard curve ranging from 0 to 224 arbitrary unit/ml. The intra- and inter-assay reproducibilities and analytical recovery of antigen were excellent. The cut-off value (38 unit/ml) was obtained as mean + 2SD, which was calculated from the antigen concentration in sera from 1,105 healthy individuals. Also described are the alterations of normal values by age, sex, and Lewis blood group status.

摘要

我们描述了一种使用由大冢检测实验室制备的放射免疫分析试剂盒,针对新肿瘤标志物唾液酸化SSEA-1(唾液酸化LeX-i)的固相免疫放射分析夹心法。该分析仅需20微升的双份样本,并参照0至224任意单位/毫升的标准曲线测定血清中唾液酸化SSEA-1抗原的浓度。抗原的批内和批间重复性以及分析回收率都非常出色。临界值(38单位/毫升)是通过1105名健康个体血清中的抗原浓度计算得出的均值加2个标准差。文中还描述了年龄、性别和Lewis血型状态对正常值的影响。

相似文献

1
[Initial basic and clinical evaluation of a solid-phase immunoradiometric assay for sialyl SSEA-1 antigen: 1. Evaluation of assay conditions and normal values].[唾液酸神经节苷脂-1抗原固相免疫放射分析的初步基础与临床评估:1. 分析条件及正常值评估]
Gan To Kagaku Ryoho. 1987 May;14(5 Pt 1):1315-21.
2
[Initial basic and clinical evaluation of a solid-phase immunoradiometric assay for sialyl SSEA-1 antigen: 2. Evaluation of clinical significance].[唾液酸化阶段特异性胚胎抗原-1抗原固相免疫放射分析的初步基础与临床评估:2. 临床意义评估]
Gan To Kagaku Ryoho. 1987 May;14(5 Pt 1):1322-31.
3
[Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for 2----6 sialyl Lewis a antigen--1. Evaluation of assay conditions and normal values].
Gan To Kagaku Ryoho. 1989 Jun;16(6):2195-202.
4
[Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl Tn antigen: (1). Evaluation of assay conditions and normal values. STN Study Group].
Gan To Kagaku Ryoho. 1989 Sep;16(9):3213-9.
5
[Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl TN antigen: (2). Evaluation of clinical significance. STN Study Group].唾液酸化Tn抗原免疫放射分析竞争抑制法的基础与临床评估:(2)临床意义评估。STN研究组
Gan To Kagaku Ryoho. 1989 Sep;16(9):3221-30.
6
[The clinical value of sialyl SSEA-1 antigen in patients with gynecologic tumors].[唾液酸化阶段特异性胚胎抗原-1抗原在妇科肿瘤患者中的临床价值]
Nihon Sanka Fujinka Gakkai Zasshi. 1987 Dec;39(12):2120-4.
7
Elevation of sialyl stage-specific mouse embryonic antigen levels in pleural effusion in patients with adenocarcinoma of the lung.肺癌腺癌患者胸腔积液中唾液酸化阶段特异性小鼠胚胎抗原水平的升高。
Cancer. 1989 Apr 1;63(7):1327-30. doi: 10.1002/1097-0142(19890401)63:7<1327::aid-cncr2820630717>3.0.co;2-q.
8
[Evaluation of CA 19-9 radioimmunoassay].[CA 19-9放射免疫测定的评估]
Gan To Kagaku Ryoho. 1984 Mar;11(3):509-14.
9
Basic evaluation of an immunoradiometric competitive inhibition assay for sialosyl-Tn antigen in sera in women. Assay conditions and normal values.女性血清中唾液酸-Tn抗原免疫放射分析竞争抑制试验的基本评估。试验条件及正常值。
Cancer. 1992 May 1;69(9):2361-7. doi: 10.1002/1097-0142(19920501)69:9<2361::aid-cncr2820690926>3.0.co;2-q.
10
Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.与CA125、CA19-9、TPA、IAP、CEA和铁蛋白相比,唾液酸化SSEA-1抗原作为卵巢癌肿瘤标志物的临床应用价值。
Nihon Sanka Fujinka Gakkai Zasshi. 1989 Feb;41(2):217-24.